Financials

  • Market Capitalization 45.2 M
  • Employee 14
  • Founded 2017
  • CEO N/A
  • Website www.werewolftx.com
  • Headquarter Delaware, United States
  • FIGI BBG00QXQ9XK4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.49
Rapporto prezzo/fatturato
-5.21

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4285
VERU
Veru Inc. - Common Stock
2.80 USD+6.46%+8.53%+20.69%+17.15%47.74 M USD
4299
TCRX
TScan Therapeutics, Inc. - Common Stock
0.73 USD-2.67%-6.41%-3.95%-59.44%46.36 M USD
4306
KPTI
Karyopharm Therapeutics Inc. - Common Stock
2.01 USD+7.49%+6.91%+3.61%-79.15%45.59 M USD
4309
GRCE
Grace Therapeutics, Inc. - Common Stock
2.14 USD+0.94%-1.38%+0.47%-46.23%45.02 M USD

Notizie